Rebirth SpA (XPAR:ALREB) Research & Development: €0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALREB Rebirth SpA XPAR:ALREB
8 GF Score
Price €2.30
! 3 Warning Signs
View Full Analysis

What is Rebirth SpA Research & Development?

Rebirth SpA XPAR:ALREB 8 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates XPAR:ALREB with a GF Score™ of 8/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Rebirth SpA's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Rebirth SpA  (XPAR:ALREB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Rebirth SpA Research & Development Related Terms

Rebirth SpA Research & Development Historical Data

* Premium members only.

The historical data trend for Rebirth SpA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rebirth SpA Research & Development Chart

Rebirth SpA Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00 0.00

Rebirth SpA Semi-Annual Data
Dec21 Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
XPAR:ALREB
8GF Score
Rebirth SpA XPAR:ALREB
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rebirth SpA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Rebirth SpA (XPAR:ALREB) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Rebirth SpA and its competitors.
Is Rebirth SpA's Research & Development too high?
Rebirth SpA's current Research & Development is €0.00 Mil. Overall, Rebirth SpA has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Rebirth SpA's Research & Development compare to competitors?
Rebirth SpA's Research & Development of €0.00 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Real Estate company?
A good Research & Development depends on the Real Estate industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Rebirth SpA and its competitors. Rebirth SpA's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rebirth SpA stock overvalued right now?
Rebirth SpA (XPAR:ALREB) has a current Research & Development of €0.00 Mil. The current Research & Development is €0.00 Mil. Rebirth SpA's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Rebirth SpA (XPAR:ALREB), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rebirth SpA Business Description

Address Via di Santa Cornelia 5, Roma, Formello, ITA, 00060
Rebirth SpA is an Italian real estate company. It is engaged in the holding, development, and management of assets for professional, residential, and tourist properties. The Company develops construction projects that it sells or rents, currently operating in the Italian and Spanish markets. The majority of the company's revenue is derived from the Sale of real estate.
8GF Score

Get the complete analysis for XPAR:ALREB

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.30
Price